Cart
sales@molnova.com
Quizartinib hydrochloride
CAS No. 1132827-21-4
Quizartinib hydrochloride ( AC-220;AC220 )
Catalog No. M10463 CAS No. 1132827-21-4
Quizartinib (AC220) is a potent, selective, second-generation FLT3 inhibitor with Kd of 1.6 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 873 | Get Quote |
|
| 50MG | 1782 | Get Quote |
|
| 100MG | 2250 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameQuizartinib hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionQuizartinib (AC220) is a potent, selective, second-generation FLT3 inhibitor with Kd of 1.6 nM.
-
DescriptionQuizartinib (AC220) is a potent, selective, second-generation FLT3 inhibitor with Kd of 1.6 nM, inhibits Wt FLT3 and FLT3-ITD autophosphorylation in MV4-11cell with IC50 of 4.2 and 1.1 nM, respectively; displays excellent kinase selectivity in a KinomeScan panel of 402 kinase binding assays, also potently inhibits PDGFRA, PDGFRB and RET; inhibits MV4-11 cell proliferarion with IC50 of 0.56 nM, demonstrates antitumor efficacy in the MV4-11 tumor xenograft model.Blood Cancer Phase 3 Clinical
-
SynonymsAC-220;AC220
-
PathwayTyrosine Kinase
-
TargetFLT3
-
RecptorFLT3
-
Research AreaCancer
-
IndicationBlood cancer
Chemical Information
-
CAS Number1132827-21-4
-
Formula Weight633.59
-
Molecular FormulaC29H34Cl2N6O4S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(C)(C)C1=CC(=NO1)NC(=O)NC2=CC=C(C=C2)C3=CN4C5=C(C=C(C=C5)OCCN6CCOCC6)SC4=N3.Cl.Cl
-
Chemical NameN-(5-tert-butyl-isoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea dihydrochloride
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zarrinkar PP, et al. Blood. 2009 Oct 1;114(14):2984-92.
2. Chao Q, et al. J Med Chem. 2009 Dec 10;52(23):7808-16.
3. Pratz KW, et al. Blood. 2010 Feb 18;115(7):1425-32.
4. Gunawardane RN, et al. Mol Cancer Ther. 2013 Apr;12(4):438-47.
2. Chao Q, et al. J Med Chem. 2009 Dec 10;52(23):7808-16.
3. Pratz KW, et al. Blood. 2010 Feb 18;115(7):1425-32.
4. Gunawardane RN, et al. Mol Cancer Ther. 2013 Apr;12(4):438-47.
molnova catalog
related products
-
Tandutinib
A potent inhibitor of FLT3, Kit and PDGFR with IC50 of 0.22, 0.17 and 0.2 uM, respectively.
-
Gilteritinib
A potent FLT3/AXL inhibitor with IC50 of 0.73 nM/0.29 nM respectively.
-
Quizartinib
Quizartinib (AC220) is a potent, selective, second-generation FLT3 inhibitor with Kd of 1.6 nM.
